Winthrop Pharmaceuticals UK Ltd

One Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 554 831
E-mail: UK-medicalinformation@sanofi-aventis.com
Medical Information Direct Line: +44 (0)1483 554 101
Medical Information Fax: +44 (0)1483 554 831

Patient Information Leaflet last updated on the eMC: 25/03/2011
PIL Molipaxin 50mg and 100mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to dosage and administration
Updated on 19/05/2009 and displayed until 25/03/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 15/08/2006 and displayed until 19/05/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 04/12/2000 and displayed until 15/08/2006
Reasons for adding or updating:
  • No reasons supplied
Updated on 04/12/2000 and displayed until 04/12/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 08/08/2000 and displayed until 04/12/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   trazodone hydrochloride